BUVIDAL

This brand name is authorized in Australia, Austria, Croatia, Estonia, Finland, Ireland, Lithuania, New Zealand, Poland, Spain, UK.

Active ingredients

The drug BUVIDAL contains one active pharmaceutical ingredient (API):

1	Buprenorphine UNII 40D3SCR4GZ - BUPRENORPHINE
	Buprenorphine is an opioid partial agonist/antagonist which attaches itself to the μ (mu) and κ (kappa) receptors of the brain. Its activity in opioid maintenance treatment is attributed to its slowly reversible link with the μ receptors which, over a prolonged period, minimises the need of illicit opioids for patients with opioid dependence.
	Read more about Buprenorphine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BUVIDAL Prolonged-release solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N07BC01	Buprenorphine	N Nervous system → N07 Other nervous system drugs → N07B Drugs used in addictive disorders → N07BC Drugs used in opioid dependence
Discover more medicines within N07BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11754P, 11759X, 11766G, 11767H, 11768J, 11773P, 11774Q
EE	Ravimiamet	1783009, 1783010, 1783021, 1783032, 1783043, 1783054, 1783065, 1849248
ES	Centro de información online de medicamentos de la AEMPS	1181336001, 1181336002, 1181336003, 1181336004, 1181336005, 1181336006, 1181336007
FI	Lääkealan turvallisuus- ja kehittämiskeskus	038314, 079803, 126957, 176345, 190471, 199899, 510809, 539928
GB	Medicines & Healthcare Products Regulatory Agency	367272, 367281, 367290, 367307, 367324, 367339, 367349
LT	Valstybinė vaistų kontrolės tarnyba	1086600, 1086601, 1086602, 1086603, 1086604, 1086605, 1086606, 1092686
NZ	Medicines and Medical Devices Safety Authority	21077, 21078, 21079, 21080, 21081, 21082, 21083
PL	Rejestru Produktów Leczniczych	100416720, 100416737, 100416743, 100416750, 100416766, 100416772, 100416789